PIA
ENSC icon

Powell Investment Advisors’s Ensysce Biosciences ENSC Stock Holding History

Powell Investment Advisors’s Portfolio ENSC Stock Details ENSC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-222
Closed -$16.2K – 134
2023
Q1 		$16.2K Buy
+222
New +$25.5K 0.01% 130
2022
Q3 		– Sell
-19
Closed -$61K – 129
2022
Q2 		$61K Buy
19
+5
+36% +$14K 0.04% 125
2022
Q1 		$57K Buy
+14
New +$92.5K 0.03% 117

Other funds holding ENSC

SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
AFM
Anson Funds Management Dallas, Texas $2.29B AUM 370.24% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PMFA
Plante Moran Financial Advisors Southfield, Michigan $1.55B AUM 17.93% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Powell Investment Advisors's ENSC Position: Q2 2023 in Review

Powell Investment Advisors sold out of Ensysce Biosciences (ENSC) in Q2 2023, closing a stake of 222 shares — an estimated $16.2K sold.

Powell Investment Advisors first reported a position in ENSC in Q1 2022 and held it in 3 quarters. The position peaked at $61K in Q2 2022. 9 funds tracked by Wall St. Rank hold ENSC as of Q2 2023.

  • Powell Investment Advisors reported no remaining Ensysce Biosciences position as of Q2 2023 after selling out during the quarter.
  • Powell Investment Advisors sold 222 Ensysce Biosciences shares in Q2 2023, an estimated $16.2K.
  • Powell Investment Advisors first reported a position in Ensysce Biosciences in Q1 2022 and held it in 3 quarters.
  • Powell Investment Advisors's Ensysce Biosciences position peaked at $61K in Q2 2022.
  • 9 funds tracked by Wall St. Rank held Ensysce Biosciences as of Q2 2023.

Based on Powell Investment Advisors's 13F filing for Q2 2023, filed 3 Aug 2023.